15 results
10-K
2023 FY
GUTS
Fractyl Health Inc.
1 Apr 24
Annual report
7:15am
-clinical studies are performed to demonstrate the health or environmental safety of new chemical or biological substances. Non-clinical (pharmaco
424B4
GUTS
Fractyl Health Inc.
2 Feb 24
Prospectus supplement with pricing info
4:18pm
controls.
Non-clinical studies are performed to demonstrate the health or environmental safety of new chemical or biological substances. Non-clinical
S-1/A
GUTS
Fractyl Health Inc.
29 Jan 24
IPO registration (amended)
6:09am
or environmental safety of new chemical or biological substances. Non-clinical (pharmaco-toxicological) studies must be conducted in compliance
S-1/A
EX-1.1
GUTS
Fractyl Health Inc.
29 Jan 24
IPO registration (amended)
6:09am
with respect to such applications.
(xxviii) Environmental Laws. Except as described in the Registration Statement, the General Disclosure Package … (collectively, “Environmental Laws”), (B) the Company and its subsidiaries have all permits, authorizations and approvals required under any
S-1
GUTS
Fractyl Health Inc.
14 Dec 23
IPO registration
3:39pm
are performed to demonstrate the health or environmental safety of new chemical or biological substances. Non-clinical (pharmaco-toxicological
S-1
EX-10.1
3js905gt
14 Dec 23
IPO registration
3:39pm
S-1
EX-10.11
n6u4d5y0
14 Dec 23
IPO registration
3:39pm
S-1
EX-10.10
c47tyd105wy8yc
14 Dec 23
IPO registration
3:39pm
DRS/A
l6l82 ll73
21 Sep 23
Draft registration statement (amended)
12:00am
DRS/A
yzilrlzoopsljl9vbjaq
22 Aug 23
Draft registration statement (amended)
12:00am
D
79v ohqu5fijhuux
25 Jan 22
$20.08M in debt, sold $20.08M, 4 investors
12:07pm
D
jwr877w oz
22 Jun 21
$100M in equity, sold $100M, 15 investors
12:34pm
D
lkt4q6 coacq
19 Mar 20
$44.75M in equity, sold $44.75M, 15 investors
10:23am
D
hol14
3 Sep 14
$48.64M in equity, sold $19.76M, 13 investors
12:00am
D
nj29u256a3h53c7
21 Mar 13
$14.35M in equity, sold $14.35M, 11 investors
12:00am
- Prev
- 1
- Next